Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Kunfukang capsule
- Development stage
- Unknown
- Lead developer
- Kanghui
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Kunfukang capsule is a traditional Chinese medicine (TCM) formulation developed and manufactured by Shaanxi Kanghui Pharmaceutical. It is approved in China for the treatment of pelvic inflammatory disease (PID) and its sequelae, particularly in patients presenting with a damp-heat stasis syndrome pattern. The capsule is composed of several herbal ingredients, including Radix Paeoniae Rubra (赤芍), Radix Sophorae Flavescentis (苦参), Polyporus (猪苓), Fructus Ligustri Lucidi (女贞子), Herba Artemisiae Anomalae (南刘寄奴), Radix Linderae (乌药), Rhizoma Dioscoreae Hypoglaucae (粉萆薢), and Herba Polygoni Avicularis (萹蓄). It exerts its therapeutic effects through anti-inflammatory, analgesic, and immunomodulatory mechanisms, improving uterine microcirculation and reducing levels of inflammatory biomarkers such as C-reactive protein (CRP), GM-CSF, and MCP-1.
- Brand names
- KunfukangWanhuashan
- Other names
- Kunfukang capsuleKunfukang jiaonang坤复康胶囊
Beyond the preview
Go deeper on Kunfukang capsule.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kunfukang capsule.